0000950170-24-106467.txt : 20240913
0000950170-24-106467.hdr.sgml : 20240913
20240913171335
ACCESSION NUMBER: 0000950170-24-106467
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240912
FILED AS OF DATE: 20240913
DATE AS OF CHANGE: 20240913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bartram Richard
CENTRAL INDEX KEY: 0001723729
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42272
FILM NUMBER: 241298585
MAIL ADDRESS:
STREET 1: C/O ESPERION THERAPEUTICS, INC.
STREET 2: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MBX Biosciences, Inc.
CENTRAL INDEX KEY: 0001776111
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12406 HORESHAM STREET
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: 3179893100
MAIL ADDRESS:
STREET 1: 12406 HORESHAM STREET
CITY: CARMEL
STATE: IN
ZIP: 46032
4
1
ownership.xml
4
X0508
4
2024-09-12
0001776111
MBX Biosciences, Inc.
MBX
0001723729
Bartram Richard
C/O MBX BIOSCIENCES, INC.
11711 N. MERIDIAN STREET, SUITE 300
CARMEL
IN
46032
false
true
false
false
Chief Financial Officer
false
Stock Option (Right to Buy)
16.00
2024-09-12
4
A
false
42578
0.00
A
2034-09-11
Common Stock
42578
42578
D
25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Richard Bartram
2024-09-13